X4 Pharmaceuticals (XFOR) News Today $0.34 -0.03 (-8.10%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period B. Riley Expects Stronger Earnings for X4 PharmaceuticalsX4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) - Equities research analysts at B. Riley raised their FY2024 earnings per share (EPS) estimates for X4 Pharmaceuticals in a research note issued to investors on Monday, November 18th. B. Riley analyst K. Patel now expects that the company willNovember 20 at 6:23 AM | marketbeat.comX4 Pharmaceuticals (NASDAQ:XFOR) Given New $4.00 Price Target at Stifel NicolausNovember 18 at 3:47 AM | americanbankingnews.comHC Wainwright Cuts Earnings Estimates for X4 PharmaceuticalsNovember 18 at 1:15 AM | americanbankingnews.comResearch Analysts Set Expectations for XFOR FY2024 EarningsX4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) - Equities research analysts at HC Wainwright decreased their FY2024 EPS estimates for shares of X4 Pharmaceuticals in a research note issued on Thursday, November 14th. HC Wainwright analyst S. Ramakanth now anticipates that the company will eNovember 18 at 1:12 AM | marketbeat.comHC Wainwright Cuts X4 Pharmaceuticals (NASDAQ:XFOR) Price Target to $1.50November 17, 2024 | americanbankingnews.comX4 Pharmaceuticals price target lowered to $1.50 from $5 at H.C. WainwrightNovember 14, 2024 | markets.businessinsider.comXFOR: Positive Results for Phase 2 Trial of Mavorixafor in Chronic Neutropenia…November 14, 2024 | msn.comX4 Pharmaceuticals Inc (XFOR) Q3 2024 Earnings Call Highlights: Strategic Engagement and ...November 14, 2024 | finance.yahoo.comX4 Pharmaceuticals Reports Positive Trial Results and ProgressNovember 14, 2024 | markets.businessinsider.comX4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare ConferenceNovember 14, 2024 | globenewswire.comX4 Pharmaceuticals price target lowered to $4 from $5 at StifelNovember 14, 2024 | markets.businessinsider.comX4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comX4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | markets.businessinsider.comX4 Pharmaceuticals Posts Wider Loss In Q3 - Quick FactsNovember 13, 2024 | markets.businessinsider.comX4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | globenewswire.comX4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)November 13, 2024 | globenewswire.comX4 Pharmaceuticals (XFOR) to Release Earnings on WednesdayX4 Pharmaceuticals (NASDAQ:XFOR) will be releasing earnings before the market opens on Wednesday, November 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639867)November 6, 2024 | marketbeat.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 1, 2024 | globenewswire.comX4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024October 24, 2024 | globenewswire.comInsider Selling: X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) CEO Sells 31,897 Shares of StockOctober 17, 2024 | insidertrades.comPaula Ragan Sells 31,897 Shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) StockX4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) CEO Paula Ragan sold 31,897 shares of the firm's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $0.56, for a total value of $17,862.32. Following the completion of the sale, the chief executive officer now directly owns 1,025,816 shares in the company, valued at $574,456.96. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.October 16, 2024 | marketbeat.comActelis Networks Announces Follow-On Order from U.S. Department of Transportation Agency Expanding Footprint to New RegionsOctober 15, 2024 | globenewswire.comX4 Pharmaceuticals (NASDAQ:XFOR) Stock Quotes, Forecast and News SummaryOctober 9, 2024 | benzinga.comX4 Pharmaceuticals, Inc. (NASDAQ:XFOR) COO Sells $38,586.15 in StockOctober 9, 2024 | insidertrades.comActelis Receives Expansion Order for Major Italian National Transportation Infrastructure ProjectOctober 2, 2024 | globenewswire.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 1, 2024 | globenewswire.comActelis Networks Receives $200,000 Order to Provide Fast Upgrade and Modernization to US Army National Guard Base NetworkSeptember 26, 2024 | globenewswire.comGV 2016 GP, L.L.C.'s Net WorthSeptember 19, 2024 | benzinga.comX4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51%September 18, 2024 | finance.yahoo.comActelis Receives New Significant Order for Major U.S. Department of Aerial Transportation AgencySeptember 9, 2024 | globenewswire.comX4 Pharmaceuticals (NASDAQ:XFOR) Shares Down 1.3% X4 Pharmaceuticals (NASDAQ:XFOR) Stock Price Down 1.3%September 6, 2024 | marketbeat.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 3, 2024 | globenewswire.comActelis Networks to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comX4 Pharmaceuticals to Participate in Upcoming September Investor ConferencesAugust 28, 2024 | globenewswire.comActelis Receives New Order for Intelligent Traffic System (ITS) Networking in New York City Metro AreaAugust 27, 2024 | globenewswire.comActelis Announces Strategic Partnership to Launch AI-Powered Cybersecurity SaaS for IoT NetworksAugust 19, 2024 | globenewswire.comActelis Networks Reports Q2 2024 Results: 372% Sequential Revenue Growth, 81% Year-Over-Year Increase, and Positive EBITDAAugust 14, 2024 | globenewswire.comXFOR: First Commercial Sales of XOLREMDI™…August 13, 2024 | msn.comHC Wainwright Comments on X4 Pharmaceuticals, Inc.'s FY2028 Earnings (NASDAQ:XFOR)X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) - Analysts at HC Wainwright increased their FY2028 EPS estimates for X4 Pharmaceuticals in a research note issued to investors on Friday, August 9th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of $0.3August 12, 2024 | marketbeat.comX4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comX4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 8, 2024 | globenewswire.comX4 Pharmaceuticals Q2 2024 Earnings PreviewAugust 7, 2024 | msn.com48Q.SG,0P0001JBQG,0 (48Q.SG)August 7, 2024 | nz.finance.yahoo.comActelis Secures New Orders for Cyber-Hardened Network Solutions for Two Major German Utility ProvidersAugust 2, 2024 | globenewswire.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2024 | globenewswire.comX4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on ThursdayX4 Pharmaceuticals (NASDAQ:XFOR) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=614861)August 1, 2024 | marketbeat.comX4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Short Interest Up 18.9% in JulyX4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 16,510,000 shares, an increase of 18.9% from the June 30th total of 13,880,000 shares. Based on an average daily trading volume, of 2,980,000 shares, the short-interest ratio is presently 5.5 days.July 28, 2024 | marketbeat.comActelis Receives Over $150,000 in New Military Orders for New Cyber-Hardened Networking SolutionsJuly 22, 2024 | globenewswire.comActelis Networks (NASDAQ:ASNS) Stock, Short Interest ReportJuly 21, 2024 | benzinga.comActelis Receives Software and Service Contract Renewal of Nearly $1.5 Million From Major North American CustomerJuly 15, 2024 | globenewswire.com Get X4 Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XFOR and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. XFOR Media Mentions By Week XFOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XFOR News Sentiment▼-0.020.45▲Average Medical News Sentiment XFOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XFOR Articles This Week▼183▲XFOR Articles Average Week Get X4 Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XFOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CDTX News Today TRVI News Today BMEA News Today TCRX News Today STRO News Today CYBN News Today MGNX News Today GNFT News Today SOPH News Today ZNTL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XFOR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XFOR Stock Alerts